Repligen (RGEN) EBT Growth (1y) (2011 - 2026)
Repligen (RGEN) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 26.74% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -80.60% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.91% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 20.26% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 14.71% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -133.49% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -57.89% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.01% |
| 10 | Repligen | 7.75 Bn | 6.77 Bn | 108.28 Mn | -77.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.69% |
| Dec 31, 2025 | 149.51% |
| Sep 30, 2025 | 1,589.30% |
| Jun 30, 2025 | 101.78% |
| Mar 31, 2025 | 114.97% |
| Dec 31, 2024 | -2,170.13% |
| Sep 30, 2024 | -110.10% |
| Jun 30, 2024 | -63.75% |
| Mar 31, 2024 | -80.09% |
| Dec 31, 2023 | -96.48% |
| Sep 30, 2023 | -76.02% |
| Jun 30, 2023 | -58.32% |
| Mar 31, 2023 | -68.51% |
| Dec 31, 2022 | 52.05% |
| Sep 30, 2022 | 15.12% |
| Jun 30, 2022 | 34.71% |
| Mar 31, 2022 | 78.01% |
| Dec 31, 2021 | 135.81% |
| Sep 30, 2021 | 132.38% |
| Jun 30, 2021 | 176.89% |